Placenta Accreta / Percreta

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Placenta Accreta / Percreta trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06849349

EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA

Placenta previa can cause a risk of severe bleeding during labor. Placenta previa is usually classified into four different types: total, partial, marginal and…

Turkey (Türkiye)48 participantsStarted 2025-02-20

All recent trials (17 shown)

CompletedNot Applicable

NCT02010229

Clinical Situations at High Risk of Placenta Accreta / Percreta

The purpose of this study is to identify what factors -either individual or related to the type of management received- influence the maternal outcomes in pregn…

France674 participantsStarted 2013-11-04

CompletedNot Applicable

NCT06808165

Relaxin and Placental Volume in Placenta Accreta Spectrum

This retrospective case-control study investigated the potential role of circulating relaxin levels and estimated placental volumes (EPV) in the pathogenesis an…

Turkey (Türkiye)40 participantsStarted 2022-01-01

Treatment: relaxin

Placenta Accreta / Percreta

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA

All recent trials (17 shown)

Clinical Situations at High Risk of Placenta Accreta / Percreta

Relaxin and Placental Volume in Placenta Accreta Spectrum

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA

All recent trials (17 shown)

Clinical Situations at High Risk of Placenta Accreta / Percreta

Relaxin and Placental Volume in Placenta Accreta Spectrum

Prediction of Placenta Accreta Outcome in Pregnant Woman With Placenta Previa Using (hcg_h ) as Abiomarkers

Bladder Suture in Uterus-Sparing Surgery and Hysterectomy for Placenta Percreta

Total Placenta Previa Associated With the Placenta Accreta Spectrum.

Peripartum Cesarean Hysterectomy for Placenta Percreta

Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta

ROTEM in Patients With Placenta Previa

Comparison of Bladder Filling vs. Non-Filling in Cesarean Hysterectomy for Placenta Percreta

Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .

Internal Iliac Artery Ligation and Abnormally Invasive Placenta

Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section

Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta

The Effectiveness of Double Incision Technique in Uterus Preserving Surgery for Placenta Percreta

ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta).